Chemtrak, Inc. provides medical information to healthcare industry professionals through the Internet. It designs and presents interactive, informational, video, and animated graphic presentations for the medical industry. The company manufactures and distributes three products in the United States: Parent's Alert Home Drug Test Service, a counselor supported home drug test service committed to helping parents prevent and eliminate drug abuse by their children (Parent's Alert Home Drug Test Service), the CholesTrak Home Cholesterol Test (CholesTrak); and ColoCARE, a Home Test to Detect the Early Warning Signs of Colorectal Disease (ColoCARE). The company's home test service permits consumers to take diagnostic tests in the privacy of their homes, mail samples to a certified testing laboratory, and receive confidential results and counseling from ChemTrak's credentialed counselors. The company is in the process of developing home test services for a variety of other health conditions including diabetes, osteoporosis, menopause and prostate cancer. ChemTrak's products are available through most major chain drug stores and mass merchandisers. Diagnostic Tests Parent's Alert Home Drug Test Service The Parent's Alert Home Drug Test Service was created to help parents prevent teen drug abuse. Company research shows that parents are open to the idea of home drug testing. Cholestrak Home Cholesterol Test CholesTrak was the first commercially available cholesterol test designed for home use. The AccuMeter-based test received FDA 510(k) clearance for professional use in 1991 (under the name AccuMeter Total Cholesterol Test) and for consumer use in 1993. CholesTrak provides an easy and accurate means for people to monitor their own cholesterol levels. Colocare, A Home Test To Detect The Early Warning Signs Of Colorectal Disease ChemTrak began selling ColoCARE in 1997. ColoCARE tests for the early warning signs of colorectal disease, which includes colon cancer, diverticulitis and hemorrhoids. The Accumeter H. Pylori test The AccuMeter H. pylori Test is a one-step, whole blood test that will indicate in minutes the presence or absence of H. pylori antibodies. Endoscopies are invasive, expensive and require trained personnel to administer, in contrast to ChemTrak's test, which is less invasive, relatively inexpensive and easy to use. The Company's AccuMeter H. Pylori Test, its first test for infectious diseases, was cleared by the FDA for professional use in 1996 and received further 510(k) clearance for improved accuracy claims in March 1997. The Accumeter Theophylline Test In 1997, ChemTrak received FDA 510(k) clearance to market its AccuMeter Theophylline Test. By monitoring concentration levels in the blood, the AccuMeter Theophylline Test allows doctors to treat asthma sufferers safely and confidently. Competition The Company’s competitors include Technical Chemical Products, Inc. (TCPI), ColoCARE, Quidel Corp., Meridien Incorporated, Psychemedics Corporation and Personal Health & Hygiene Inc. History The company was founded in 1985 as ChemTrak Incorporated and changed its name to Medivisor Marketing, Inc. in May 2006 and then to Chemtrak, Inc. in August 2006.
chemtrak inc (CTKI:OTC US)
929 East Arques Avenue
Sunnyvale, CA 94086
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for CTKI.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact CHEMTRAK INC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.